BrioHealth Solutions, a US-based company developing the BrioVAD System, a Left Ventricular Assist Device (LVAD), announced on Monday that the 100th participant has been enrolled in the system's INNOVATE Trial.

Launched in late 2024, the INNOVATE Trial is a national research study to evaluate an innovative mechanical heart pump designed to help patients whose hearts can no longer pump enough blood on their own. The trial aims to evaluate the BrioVAD System to develop more reliable and longer-lasting devices that can improve both survival and quality of life.

The BrioVAD System is designed to augment blood flow, enhance patient comfort, and minimise complications, while prioritising patient well-being and reduce the occurrence of adverse events associated with advanced heart failure treatment.